We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals
SNDX

27 hedge funds and large institutions have $126M invested in Syndax Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+27
Holders Change %
–
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
27
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MAM
MPM Asset Management
Massachusetts
+$27.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$26.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$16.6M
4
O
OrbiMed
New York
+$9.52M
5
EC
EcoR1 Capital
California
+$6.42M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
1
MPM Asset Management
Massachusetts
$28.9M +$27.3M +2,168,691 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$27.9M +$26.3M +2,094,464 New
Wellington Management Group
3
Wellington Management Group
Massachusetts
$17.6M +$16.6M +1,318,028 New
O
4
OrbiMed
New York
$10.1M +$9.52M +757,365 New
EC
5
EcoR1 Capital
California
$6.8M +$6.42M +510,829 New
Jennison Associates
6
Jennison Associates
New York
$5.98M +$5.79M +460,892 New
BA
7
BlackRock Advisors
Delaware
$4.11M +$3.88M +308,693 New
TAM
8
Tiverton Asset Management
Delaware
$3.85M +$3.63M +288,750 New
RG
9
Redmile Group
California
$3.5M +$3.31M +263,000 New
BC
10
Boxer Capital
California
$3.12M +$2.94M +234,220 New
CAM
11
Cormorant Asset Management
Massachusetts
$2.86M +$2.7M +214,419 New
BG
12
BlackRock Group
United Kingdom
$2.38M +$2.25M +178,626 New
Alyeska Investment Group
13
Alyeska Investment Group
Illinois
$2.33M +$2.2M +175,000 New
ACH
14
ArrowMark Colorado Holdings
Colorado
$2M +$1.88M +149,931 New
USAA
15
United Services Automobile Association
Texas
$772K +$729K +57,990 New
GE
16
General Electric
Ohio
$715K +$674K +53,646 New
Millennium Management
17
Millennium Management
New York
$628K +$592K +47,114 New
BlackRock
18
BlackRock
New York
$594K +$561K +44,595 New
KCM
19
Kornitzer Capital Management
Kansas
$533K +$503K +40,000 New
Goldman Sachs
20
Goldman Sachs
New York
$353K +$333K +26,500 New
Norges Bank
21
Norges Bank
Norway
$333K +$314K +25,000 New
BIM
22
BlackRock Investment Management
Delaware
$241K +$227K +18,086 New
Morgan Stanley
23
Morgan Stanley
New York
$46K +$43.7K +3,479 New
Deutsche Bank
24
Deutsche Bank
Germany
$39K +$37.6K +2,989 New
TRCT
25
Tower Research Capital (TRC)
New York
$11K +$10.8K +863 New
1
2

SNDX Hedge Fund Activity: Q1 2016 in Review

27 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Syndax Pharmaceuticals (SNDX) for Q1 2016, worth a combined $126M.

Buyers outnumbered sellers: 27 funds opened new SNDX positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was MPM Asset Management, opening a new position worth an estimated $27.3M.

  • 27 institutional investors held Syndax Pharmaceuticals (SNDX) as of Q1 2016, up from 0 in Q4 2015.
  • Funds reported $126M of Syndax Pharmaceuticals stock for Q1 2016.
  • 27 funds opened new Syndax Pharmaceuticals positions in Q1 2016 and 0 closed out, a net change of +27 holders.
  • The largest Syndax Pharmaceuticals buyer in Q1 2016 was MPM Asset Management, an estimated $27.3M added.

Based on aggregated 13F filings for Q1 2016.